Emergent BioSolutions’ C.E.O. announced several executive changes but vigorously defended the company, which is on track for record revenues.Emergent BioSolutions’ C.E.O. announced several executive changes but vigorously defended the company, which is on track for record revenues.Coronavirus (2019-nCoV), Vaccination and Immunization, Factories and Manufacturing, Emergent BioSolutions Inc, Government Contracts and Procurement, Drugs (Pharmaceuticals), Regulation and Deregulation of Industry, Johnson & Johnson, AstraZeneca PLCRead More
